Mouse anti Influenza A Nucleoprotein antibody, clone 1341 Influenza A nucleoprotein. Mouse anti Influenza A Nucleoprotein antibody, clone 1341 reacts against all strains of Influenza A.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.1% Sodium Azide (NaN3)
1% Bovine Serum Albumin
- Partially purified Influenza A.
- Approx. Protein Concentrations
- IgG concentration 0.1mg/ml
- Store at +4oC or at -20oC if preferred.
This product should be stored undiluted.
Storage in frost-free freezers is not recommended. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of Influenza A Nucleoprotein antibody
|Immunohistology - Frozen 1
|Immunohistology - Paraffin
- 1The epitope recognised by this antibody is reported to be sensitive to formaldehyde fixation and tissue processing. Bio-Rad recommends the use of acetone fixation for frozen sections.
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Application Based External Images
Product Specific References
References for Influenza A Nucleoprotein antibody
Liang, Y. et al. (2005) cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments.
J Virol. 79: 10348-55.
Petersen, H. et al. (2012) Replication and adaptive mutations of low pathogenic avian influenza viruses in tracheal organ cultures of different avian species.
PLoS One. 7: e42260.
Sid, H. et al. (2016) Mycoplasma gallisepticum modifies the pathogenesis of influenza A virus in the avian tracheal epithelium
International Journal of Medical Microbiology. Apr 6 [Epub ahead of print]